Rapid Mycoplasma Negativity Testing Service

Compliant with guidelines from various countries such as JP, EP, and USP, capable of total implementation from validation to actual measurement and technology transfer.

Our company can conduct a total range of services from validation of mycoplasma detection tests (nucleic acid amplification test: NAT) to actual measurements and technology transfer using analysis equipment managed in compliance with GMP regulations. 【Features】 ■ Over 20 years of experience in mycoplasma detection tests as part of the Eurofins BPT (BioPharma Product Testing) network ■ After technology transfer, tests can be conducted using a method with control DNA, allowing for low-risk and low-cost testing ■ Requests for feasibility studies only are also possible ■ Possession of analysis equipment managed in compliance with GMP regulations The Eurofins BPT network has been focusing on mycoplasma detection tests for many years, including culture methods, and has strengths in regulatory approvals and accumulated know-how overseas. We will utilize this know-how to structure mycoplasma detection tests and propose optimal test designs. For more detailed information, please refer to the "Related Links."

Other Testing Contract